Page last updated: 2024-10-31
midazolam and Cephalgia Syndromes
midazolam has been researched along with Cephalgia Syndromes in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "On the basis of a small number of case studies, IV propofol has been advocated for the treatment of chronic daily headache (CDH)." | 9.14 | The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial. ( Dick, BD; Gray, DP; Jamieson-Lega, KI; Rashiq, S; Simmonds, MK; Sobolev, IA; Stewart, BJ, 2009) |
| "On the basis of a small number of case studies, IV propofol has been advocated for the treatment of chronic daily headache (CDH)." | 5.14 | The effect of single-dose propofol injection on pain and quality of life in chronic daily headache: a randomized, double-blind, controlled trial. ( Dick, BD; Gray, DP; Jamieson-Lega, KI; Rashiq, S; Simmonds, MK; Sobolev, IA; Stewart, BJ, 2009) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Simmonds, MK | 1 |
| Rashiq, S | 1 |
| Sobolev, IA | 1 |
| Dick, BD | 1 |
| Gray, DP | 1 |
| Stewart, BJ | 1 |
| Jamieson-Lega, KI | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| The Effect of Single-dose Propofol Injection on Pain and Quality of Life in Chronic Daily Headache: a Randomized Double-blind Controlled Trial[NCT00228267] | Phase 2 | 28 participants (Anticipated) | Interventional | 2004-09-30 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for midazolam and Cephalgia Syndromes